WHO ICTRP trial
Study conducted to see the effect of Ayurvedic Formulation as an add-on drug to…
CTRI/2025/02/080255 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/02/080255 |
|---|---|
| Public title | Study conducted to see the effect of Ayurvedic Formulation as an add-on drug to evaluate lipid profile and ecg changes in the Ischemic Heart Disease |
| Scientific title | Evaluation of Ayurvedic Formulation as an add-on drug in the Ishemic Heart Disease with special reference to Vataj Hridrog - NIL |
| Primary sponsor | Dr Shweta Patil |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: I00-I99- Diseases of the circulatory system |
| Registration date | Oct 2, 2025 |
| Target size | 31 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: